Search

everythinglearnresearchcommunity

for

Search:↓

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Postmenopausal women can experience hairline recession, affecting their quality of life, and more research is needed for treatments.

Ovarian Hyperthecosis caused hypersexuality in an older woman and was successfully treated with surgery.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Clomiphene testing can help find ovarian causes of high testosterone in postmenopausal women.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Hair loss in postmenopausal woman caused by ovarian issue.

Alopecia patients have less GPER-1, which might affect hair loss.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

High testosterone increases heart disease risk in women with PCOS.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Testosterone protects female heart cells from stress by activating estrogen receptors.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

The document concludes that doctors should thoroughly check postmenopausal women with sudden increased male traits for rare conditions like androgen-producing endometrial cancer.

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.